Long-acting follicle-stimulating hormone versus daily follicle-stimulating hormone for women undergoing assisted reproduction

被引：11

作者：

Pouwer, Annefloor W. ^{[1
]}

Farquhar, Cynthia ^{[2
]}

Kremer, Jan A. M. ^{[3
]}

Marjoribanks, Jane ^{[2
]}

机构：

[1] Rijnstate Hosp, Dept Obstet & Gynaecol, Arnhem, Netherlands

[2] Univ Auckland, Dept Obstet & Gynaecol, Auckland 1, New Zealand

[3] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, NL-6525 ED Nijmegen, Netherlands

来源：

FERTILITY AND STERILITY | 2016年 / 105卷 / 06期

关键词：

Follicle stimulating hormone; luteinizing hormone; assisted reproductive techniques; in vitro fertilization; intracytoplasmic sperm injection;

D O I：

10.1016/j.fertnstert.2016.01.041

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Follicle-stimulating hormone (FSH) given as a weekly injection in a medium dose is as safe and effective as a daily FSH injection for women undergoing assisted reproduction. (Fertil Steril (R) 2016;105:1454-6. (C) 2016 by American Society for Reproductive Medicine.)

引用

页码：1454 / 1456

页数：3